Photo of Temidayo Fadelu,  MD, MPH

Temidayo Fadelu, MD, MPH

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute


temidayo_fadelu@dfci.harvard.edu

Temidayo Fadelu, MD, MPH

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Instructor, Medicine, Harvard Medical School
  • Physician, Medical Oncology, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Research Abstract

In my clinical and research experiences, I have frequently observed a disconnect between evidence-based knowledge and integration into real-world clinical practice. Behavioral change at the health system, clinician, and patient levels often lags behind published evidence by several years or even decades. I am developing expertise in implementation research in order to close this gap between evidence and application. In particular, I am interested in studying strategies to effectively adopt, adapt, and integrate evidence-based health-interventions into low-resource health settings.

Publications

Powered by Harvard Catalyst
  • Fadelu T, Rebbeck TR. The rising burden of cancer in low- and middle-human development index countries. Cancer 2021. PubMed
  • Erfani P, Bhangdia K, Stauber C, Mugunga JC, Pace LE, Fadelu T. Economic Evaluations of Breast Cancer Care in Low- and Middle-Income Countries: A Scoping Review. Oncologist 2021. PubMed
  • Erfani P, Bhangdia K, Mugunga JC, Pace LE, Fadelu T. Cost of breast cancer care in low and middle-income countries: a scoping review protocol. JBI Evid Synth 2021. PubMed
  • Martei YM, Rick TJ, Fadelu T, Ezzi MS, Hammad N, Quadri NS, Rodrigues B, Simonds H, Grover S, Incrocci L, Vanderpuye V. Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in Africa. JCO Glob Oncol 2021; 7:368-377. PubMed
  • Fadelu T, Damuse R, Lormil J, Pecan E, Dubuisson C, Pierre V, Rebbeck T, Shulman LN. Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort. Oncologist 2021; 25:e1372-e1381. PubMed
  • Fadelu T, Damuse R, Lormil J, Pecan E, Greenberg L, Dubuisson C, Pierre V, Triedman SA, Shulman LN, Rebbeck TR. Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast Cancer. JCO Glob Oncol 2021; 6:1656-1665. PubMed
  • DeBoer RJ, Fadelu TA, Shulman LN, Van Loon K. Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic. JAMA Oncol 2021; 6:1429-1433. PubMed
  • Fadelu T, Zhang S, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson AB, Atienza DM, Messino M, Kindler HL, Venook A, Ogino S, Ng K, Wu K, Willett W, Giovannucci E, Meyerhardt J, Bao Y, Fuchs CS. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol 2018. PubMed
  • Fadelu T, Shulman LN. Health policy: Towards greater equity in the global oncology workforce. Nat Rev Clin Oncol 2019; 15:270-272. PubMed
  • Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho A. Bringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer 2014; 14:815-21. PubMed